文献速递疝与腹壁外科围术期管理与 ERAS

皮肤闭合前化学血栓预防增加腹壁疝修补术后出血风险

Chemical thromboprophylaxis before skin closure increases bleeding risk after major ventral hernia repair: A multicenter cohort study.
PubMed 文献 · Surgery · 2022-03-02

这项多中心回顾性队列研究分析了2014至2019年澳大利亚14家医院的3384例择期腹壁疝修补术,发现化学血栓预防时机差异大,早期给药(皮肤闭合前)较术后给药或不给药显著增加出血风险,而临床静脉血栓栓塞发生率低且与给药时机无关。

要点

  • 择期腹壁疝修补术后临床静脉血栓栓塞发生率为0.2%,与化学血栓预防时机无关。
  • 早期化学血栓预防(皮肤闭合前)较术后给药增加出血风险(OR 1.98)。
  • 早期化学血栓预防较不给药增加出血风险(OR 2.83)。

核心结论

  • 择期腹壁疝修补术后临床静脉血栓栓塞发生率低,围术期血栓预防时机差异大,早期化学血栓预防增加出血风险且未显著额外预防静脉血栓栓塞。

主要发现

  • 化学血栓预防早期(皮肤闭合前)、术后、未给药分别为856例(25.3%)、1701例(50.3%)、827例(24.4%),在不同外科医生、受训人员和机构间存在差异。
  • 临床静脉血栓栓塞发生6例(0.2%),与化学血栓预防时机无关。
  • 术后出血134例(4.0%),其中大出血67例(50%),41例(30.6%)需手术控制。
  • 出血延长住院时间(均值[标准差]7.0(13.9)天 vs 2.6(4.7)天,P < .001)。
  • 早期给药较术后给药(OR 1.98;95%CI 1.36-2.88;P < .001)和未给药(OR 2.83;95%CI 1.70-4.89;P < .001)显著增加出血风险,并独立预测出血发生。

临床怎么用

  • 择期腹壁疝修补术围术期化学血栓预防时机需权衡出血与静脉血栓栓塞风险,早期给药(皮肤闭合前)增加出血风险。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Major ventral hernia surgeries are commonly performed. Despite guideline recommendations for chemo-thromboprophylaxis in the perioperative period, the optimal timing for its initiation is unknown. We characterized the variability in perioperative chemoprophylaxis in elective major ventral hernia surgery and determine whether timing of chemoprophylaxis affects bleeding and symptomatic venous thromboembolism. METHODS: Retrospective analysis of all elective major ventral hernia surgery undertaken between January 1, 2014, and December 31, 2019, at 14 hospitals across Australia. Major bleeding was defined as the need for blood transfusion, reoperation, or >20 g/L fall in hemoglobin. Clinical venous thromboembolism was defined as imaging-proven symptomatic disease <30 days postsurgery. Propensity score matched analysis was used to validate primary findings. RESULTS: In the study, 3,384 hernia repairs were analyzed. Chemoprophylaxis was administered early (before skin closure), postoperatively, or not given in 856 (25.3%), 1,701 (50.3%), and 827 (24.4%) patients, respectively. This varied between surgeons, trainees, and institutions. Clinical venous thromboembolism occurred in 6 (0.2%) patients and was unrelated to chemoprophylaxis timing. 134 (4.0%) patients had postoperative bleeding, with 67 (50%) major bleeds, requiring surgical control in 41 (30.6%) cases. Bleeding extended duration of stay (mean [standard deviation], 7.0 (13.9) vs 2.6 (4.7) days, P < .001). Notably, compared with postoperative (odds ratio 1.98; 95% confidence interval, 1.36-2.88; P < .001) and no (odds ratio 2.83; 95% confidence interval, 1.70-4.89; P < .001) chemoprophylaxis, early initiation significantly increased bleeding risk and independently predicted its occurrence. CONCLUSION: The incidence of clinical venous thromboembolism after elective major ventral hernia repair is low. Variability in perioperative thromboprophylaxis is high. Early chemoprophylaxis increases bleeding risk without appreciable additional protection from venous thromboembolism.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Chemical thromboprophylaxis before skin closure increases bleeding risk after major ventral hernia repair: A multicenter cohort study. Surgery. 2022. PMID: 35248362. doi:10.1016/j.surg.2022.01.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。